Products

Lipecelte®

Trabectedin

Indications

  • Adult patients with advanced soft tissue sarcoma (STS) who have failed treatment with anthracyclines and ifosfamide, or who are not candidates for such products
  • Patients with platinum-sensitive recurrent ovarian cancer, in combination with pegylated liposomal doxorubicin (PLD).

Presentations

  • LIPECELTE® is supplied in a single-dose glass vial containing 1 mg of trabectedin